Search

Search Constraints

You searched for: Author/Creator Dummer, Reinhard

Search Results

92. Expanded access programmes: patient interests versus clinical trial integrity. Issue 1 (January 2015)

93. Expanded access programmes: patient interests versus clinical trial integrity. Issue 1 (January 2015)

94. Expression of programmed death-1 (PD-1) and its ligands in Sézary syndrome. (2019)

95. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. (November 2017)

96. Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma. (March 2019)

97. Future perspectives in melanoma research. Issue 1 (December 2016)

98. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd–6th 2014. Issue 1 (December 2015)

99. Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma. (November 2016)

100. Health-related quality of life results from the phase III CheckMate 067 study. (September 2017)